UBS Maintains Neutral on Insulet, Raises Price Target to $171
Benzinga Newsdesk 8 hours ago
Analyst RatingsNewsPrice Target
UBS analyst Patrick Wood maintains Insulet (NASDAQ:PODD) with a Neutral and raises the price target from $150 to $171.
UBS analyst Patrick Wood maintains Insulet (NASDAQ:PODD) with a Neutral and raises the price target from $150 to $171.